17/12/2015

ESTEVE’S LAXADINA, VOTED PRODUCT OF THE YEAR BY CONSUMERS

The only contest in Spain where consumers directly vote on the most innovative high-volume products of the year.

The product will carry the "Voted Product of the Year" logo, a seal that recognizes this award and offers added quality and trust.

ESTEVE's Laxadina, an over-the-counter, plant-based laxative prescribed to treat occasional constipation, has been voted Product of the Year 2016 by consumers at the 16 Grand Prize for Innovation Award Ceremony. More than 10,000 consumers all over Spain have voted on the most innovative products launched in the last year.

The innovative laxative combination of Laxadina is recognized by consumers and entitles this product to carry the "Product of the Year" logo throughout the year 2016, a seal that recognizes this award and offers added quality and trust.

Laxadina contains two ingredients of plant origin: Plantago Ovata, which increases fecal volume and stimulates intestinal motility; and Rhamnus Frangula, which stimulates the intestinal mucosa to facilitate bowel movement, thus providing rapid onset of action and good tolerability. Also, it is presented in convenient cartons of 16 single-dose sachets filled with pleasant orange flavored powder, to be taken with water or fruit juice just before or during meals.

The Product of the Year, which celebrates its sixteenth edition this year, is the only contest in Spain where consumers vote directly on the most innovative consumer products. It is considered the largest study on consumer-centered R&D in our country. The intended objective of this contest is to bring the most innovative products closer to consumers and to reward the effort made by brands in terms of innovation. This year, a total of 32 products in different categories have been awarded Product of the Year 2016 recognition by consumers.


You can follow ESTEVE on Twitter at this link: twitter.com/esteve_news.

Related Information

Last news

  • THE PROGRAM ’PLAN PROFARMA’ HAS ONCE AGAIN QUALIFIED ESTEVE’S R&D&I AS ’’EXCELLENT’’

    Once again, ESTEVE's research activity has received the qualification ''Excellent'' in the Program 'Plan Profarma' (Program for Fostering Scientific Research, Technological Development and Innovation ...

    read more
  • PENSA PHARMA HAS BEEN AWARDED A PRIZE FOR ITS BEST DEVELOPMENT AND COMMERCIALIZATION OF GENERIC MEDICINES

    Pensa Pharma (PENSA), a company of the ESTEVE Group specialized in generic medicines, has been awarded a prize at the II edition of La Razón Comunidad Valenciana Awards. Specifically, PENSA has receiv...

    read more
  • ESTEVE APPOINTS THOMAS B. RIISAGER AS CHIEF CORPORATE STRATEGY & BUSINESS DEVELOPMENT OFFICER

    ESTEVE has announced today the appointment of Thomas B Riisager as Chief Corporate Strategy & Business Development Officer, to be heading Corporate Strategy & Business Development for the pharmaceutic...

    read more

Follow us at

This Website uses its own and third-party cookies to improve our services and analyse the user's browsing habits. If you continue browsing, we will consider you to have accepted their use. You can find more information by visiting our Cookies policy.